Corline Biomedical Stock

Corline Biomedical Net Margin

The Net Profit Margin of Corline Biomedical (CLBIO.ST) as of Jul 27, 2026 is -192.31 %. In the previous year, Net Profit Margin was -237.28 % — a change of -18.95% (higher).

Net Margin

-192.31 %

YoY

-18.95%

Last updated:

Net Profit Margin of Corline Biomedical is 2026 -192.31 % . Net Profit Margin of Corline Biomedical was 2025 -237.28 % . It decreases by -18.95% higher compared to the previous year.

For Corline Biomedical, the net margin of -192.3% is down versus -97.9% a few years ago.

Access this data via the Eulerpool API

Corline Biomedical Stock analysis

What does Corline Biomedical do? Corline Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corline Biomedical stock

Net Profit Margin of Corline Biomedical is -192.31 % in 2026.

Access this data via the Eulerpool API

Margins — Corline Biomedical

All Key Metrics — Corline Biomedical